Which specific treatments for recurrent implantation failure lack reported safety data in reviews?
Several treatments for recurrent implantation failure (RIF) are being studied, but not all have adequate safety data reported in reviews. Two notable examples are regulatory T cell (Treg)-targeting therapies and platelet-rich plasma (PRP) infusion. While PRP has some safety concerns noted, Treg-targeting strategies lack any reported safety outcomes.
What the research says
A 2025 review of Treg-targeting strategies for pregnancy complications, including RIF, notes that emerging interventions such as immunometabolic reprogramming and engineered cellular therapies like chimeric antigen receptor (CAR) Tregs are being explored. However, the review explicitly states that these strategies lack reported outcomes or safety data 3. Similarly, a systematic review of intrauterine PRP infusion for RIF found that while PRP improved pregnancy rates, the preterm birth rate was significantly higher in the PRP group compared to controls (OR 8.24, 95% CI 2.09–32.41) 4. This indicates a potential safety concern, but broader safety data beyond this outcome are limited. In contrast, other treatments like acupuncture have been evaluated for safety and efficacy in meta-analyses, with no major safety issues reported 2. The Elgheriany Reproductive Immunology Framework emphasizes the need for cautious interpretation of immune findings before initiating immunotherapy, highlighting the lack of safety data for many immune-directed therapies 1.
What to ask your doctor
- What safety data are available for Treg-targeting therapies like immunometabolic reprogramming or CAR Tregs in RIF?
- Given the increased preterm birth risk with PRP, how do you weigh the benefits and risks for my case?
- Are there any ongoing trials or registries tracking long-term safety of these emerging treatments?
- How does the lack of safety data for certain immunotherapies affect your recommendation for my treatment plan?
This question is drawn from common patient questions about this topic and answered using cited medical research. We do not provide individualized advice.